(NewsDirect)
Valeo Pharma CEO Steve Saviuk joined SteveDarling from Proactive to share details about recent executive changeswithin the company.
Saviukannounced the appointment of Pascal Tougas as the new chief financialofficer, succeeding Luc Mainville.
Tougas is recognized as a well-experienced senior executive inthe pharmaceutical industry, with a robust financial background. Hisprevious tenure at Sanofi Canada for 11 years saw him in various keyroles, including Country Head, Trade and Revenue Management, interimChief Financial Officer Canada, and Director Controlling andOperations Canada, among others.
Pascal is also well-qualified academically, holding abachelor's degree in business administration from HEC Montrealalong with a CPA designation.
Additionally, Saviuk informedProactive about Valeo Pharma’s strategic efforts aimed at reducingoperational costs as the company advances towards profitability. Onesignificant move in this direction is the realignment of thecompany’s organizational structure. This realignment is expected toyield cost savings while enhancing the efficiency and timeliness ofdecision-making within the company. These changes are projected tosave the company over $2 million.
ContactDetails
Proactive
+1 347-449-0879
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.